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Abstract
The product FRA® Octazyme C Dry contains eight enzymes and is intended to be used as a zootechnical
additive for chickens for fattening and weaned piglets. In a previous opinion of the EFSA Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP), the additive was characterised in
full, including the production strains of the enzymes, the safety and the efficacy of the product. In that
assessment, the FEEDAP Panel concluded that the additive was safe for the consumers of food products
obtained from animals fed with the additive and that the additive would pose no risks to the
environment. Regarding the safety for the users, the Panel could not conclude on the potential of the
additive to be irritant to the skin and eyes or on its skin sensitising properties, but the additive should be
considered a potential respiratory sensitiser. In the trials submitted to support the safety for the target
species and the efficacy of the additive, the analytical results of the enzyme activities did not confirm the
intended enzyme activities and therefore the FEEDAP Panel could not draw conclusions on the tolerance
and the efficacy of the additive. In the current application, the applicant has provided new analysis of the
feeds used in the tolerance and efficacy trials. The data have been obtained using a modified extraction
procedure which has demonstrated to permit a higher recovery of the enzyme activity in supplemented
and non-supplemented feeds. However, the enzyme activities obtained in the experimental diets using
the new analytical method showed increases but also decreases of the enzyme activity compared to the
previously submitted data. Therefore, the change in the enzyme activities could not be ascribed to the
analytical method only. The Panel concluded that the new data cannot be considered as those reflecting
the actual supplementation levels of the additive in the diets and therefore could not conclude on the
safety and efficacy of the target species.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for animal nutrition and, in particular, Article 9 defines the terms of the authorisation by the
Commission.
The applicant, Framelco B.V., is seeking a Community authorisation of a-galactosidase, a-amylase,
endo-1,3(4)-b-glucanase, endo-1,4-b-glucanase, mannan-endo-1,4-b-mannosidase, pectinase, protease,
endo-1,4-b-xylanase as a feed additive to be used as a digestibility enhancer for piglets (weaned) and
chickens for fattening (Table 1).
On 6 July 2017, the Panel on Additives and Products or Substances used in Animal Feed of the
European Food Safety Authority (“Authority”), in its opinion on the safety and efficacy of the product
could not conclude on the safety and efficacy for the target species due to the limitations identified in
the studies provided.
The Commission gave the possibility to the applicant to submit complementary information in order
to complete the assessment and to allow a revision of Authority’s opinion. The new data have been
received on 13 September 2018.
In view of the above, the Commission asks the Authority to deliver a new opinion on a-galactosidase,
a-amylase, endo-1,3(4)-b-glucanase, endo-1,4-b-glucanase, mannan-endo-1,4-b-mannosidase, pectinase,
protease, endo-1,4-b-xylanase as a feed additive for piglets (weaned) and chickens for fattening based on
the additional data submitted by the applicant.
1.2. Additional information
The FEEDAP Panel issued an opinion on the safety and efficacy of the product Fra® Octazyme C
Dry as a feed additive for chickens for fattening and weaned piglets (EFSA FEEDAP Panel, 2017). The
Panel could not conclude on the safety or the efficacy of the additive for the target species. The
applicant has provided new data to address the limitations previously identified regarding the safety
and the efficacy for the target species.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of supplementary
information2 to a previous application on the same product.3
Table 1: Description of the substances
Category of additive Zootechnical additive
Functional group of
additive
Digestibility enhancers
Description a-galactosidase, a-amylase, endo-1,3(4)-b-glucanase, endo-1,4- b-glucanase,
mannan-endo-1,4-b-mannosidase, pectinase, protease, endo-1,4-b-xylanase
Target animal category Piglets (weaned) and chickens for fattening
Applicant Framelco B.V.
Type of request New opinion
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 FEED dossier reference: FAD-2018-0052.
3 FEED dossier reference: FAD-2014-0028.
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efficacy of Fra®
Octazyme C Dry (endo-1,4-b-xylanase, mannan-endo-1,4-b-mannosidase, a-amylase, endo-1,3(4)-b-
glucanase, pectinase, endo-1,4-b-glucanase, protease, a-galactosidase) is in line with the principles
laid down in Regulation (EC) No 429/20084 and the relevant guidance documents: Technical guidance:
Tolerance and efficacy studies in target animals (EFSA FEEDAP Panel, 2011) and Guidance on
zootechnical additives (EFSA FEEDAP Panel, 2012).
3. Assessment
The product FRA® Octazyme C Dry is available in powder form and contains a minimum activity of
160,000 BXU of endo-1,4-b-xylanase (xylanase), 1,000 UM of mannan-endo-1,4-b-mannosidase
(mannanase), 10,000 UA of a-amylase (amylase), 20,000 BU of endo-1,3(4)-b-glucanase (glucanase),
1,500 UPR of protease, 3,200 UG of endo-1,4-b-glucanase (cellulase), 2,100 UP of pectinase and 80
GALU of a-galactosidase (galactosidase) per gram of product.5 The additive is intended to be used as
a zootechnical additive (functional group: digestibility enhancers) in feed for chickens for fattening and
weaned piglets at a recommended level of 50 mg additive/kg feed (delivering 8,000 BXU xylanase
units, 50 UM mannanase, 500 UA amylase, 1,000 BU glucanase, 75 UPR protease, 160 UG cellulase, 105
UP pectinase and 4 GALU galactosidase per kg feed).
In a previous opinion of the FEEDAP Panel, the additive was characterised in full, including the
production strains of the enzymes; also the safety and the efficacy of the product were evaluated (EFSA
FEEDAP Panel, 2017). In that assessment, the Panel concluded that the additive is safe for the consumers
of food products obtained from animals fed with the additive and that the additive would pose no risks to
the environment. Regarding the safety for the users, the Panel could not conclude on the potential of the
additive to be irritant to the skin and eyes or on its skin sensitising properties, but owing to the nature of
the active substances, the FEEDAP Panel concluded that the additive should be considered a potential
respiratory sensitiser.
In the above-mentioned opinion, one tolerance and three efficacy trials each in chickens for
fattening and weaned piglets were assessed. The analytical results of the diets used did not confirm
the intended dosages (Appendix A). The non-supplemented diets presented in most of the cases
enzyme activities close or even higher than the ones in the diets supplemented with the recommended
dose. In the tolerance trials, the 100-fold level was not reached, while, in some of the efficacy trials,
the supplemented diets showed enzyme activities that were higher than the intended ones
(Appendix A; Table A.1). Moreover, the method of analysis used in some of the efficacy trials and for
some of the enzymes had a limit of detection/quantification higher than the enzyme activity
recommended (Appendix A; Tables A.2 and A.3). Considering all these limitations on the analysis of
the enzyme activities present in the feeds offered to the animals, the FEEDAP Panel could not draw
conclusions on the tolerance and the efficacy trials.
The applicant has provided new data to address the limitations identified regarding the enzyme
activities analysed in the experimental diets.
The applicant re-analysed samples of the diets used in the tolerance and efficacy trials which had
been stored since the conduct of the studies (2011–2012) under vacuum and at 20°C. The analytical
methods used in this new analysis were those previously described by the applicant but included a
modification of the extraction procedure. The modification consisted in an adjustment of the temperature
at which the extraction is done, the buffer used, and the stirring method applied. The feed samples were
not re-analysed using the non-modified extraction procedure at the time the new analysis was
conducted, which would have allowed a comparison between the two extraction methods.
The enzyme activities resulting from the new analysis are given in the tables presented in the
Appendix A. The results obtained in the non-supplemented diets showed in most of the cases lower
enzyme activities than those previously reported and assessed in 2017. With regard to the supplemented
diets, the new analysis showed a better correspondence with the intended enzyme activities. The new
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
5 The details on the enzyme activities definition given in https://ec.europa.eu/jrc/sites/jrcsh/files/finirep-fad-2014-0028-fraocta
zymec.pdf
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enzyme activities were in some cases higher and in some other cases lower compared to the previously
reported, with no clear tendency/pattern and with different magnitude between diets and enzymes.
The different behaviour of the new extraction step between diets and enzymes was not explained
by the data submitted. Therefore, the applicant was requested to perform a comparison of the two
analytical methods with the diets used in the studies to evaluate the effect of the new extraction
method. This comparison was not done because no more samples of the experimental feeds were
available. Instead, the applicant provided a comparison of the eight enzyme activities in feed when
using the extraction procedure or not using it. The feeds used in this comparison had a similar
composition to those used in the trials previously evaluated and were supplemented or not with the
additive.6 The results showed that the samples analysed using the new extraction method had, in all
cases, higher enzyme activities than the samples analysed not using the new extraction method.
However, the results found in the re-analysis of the feeds used in the trials did not indicate such
pattern (i.e. increases of the enzyme activity in all cases). Consequently, the change in the enzyme
activities of the diets used in the tolerance and efficacy trials could not be ascribed only to the
extraction method, but also to other non-explained factors. In the absence of a clear explanation for
the differences observed, the FEEDAP Panel is not in a position to accept the new analytical results as
those reflecting the actual supplementation levels of the additive in the diets. Therefore, the FEEDAP
Panel reiterates its previous opinion that no conclusions on the safety and the efficacy of the additive
in chickens for fattening and piglets can be drawn with the current set of data.
The FEEDAP Panel noted that the newly provided results are in some cases below the previously
reported limit of quantification (LOQ), but the applicant has not properly explained how quantification
was done for values below the limit of quantification.
3.1. Conclusions on the safety and efficacy for the target species
The FEEDAP Panel is not in the position to accept the new analytical results, as those reflecting the
actual supplementation levels of the additive in the diets. Therefore, the Panel reiterates its previous
opinion that no conclusions on the safety and the efficacy of the additive in weaned piglets and
chickens for fattening can be drawn with the current set of data.
3.2. Post-market monitoring
The FEEDAP Panel considers that there is no need for specific requirements for a post-market monitoring
plan other than those established in the Feed Hygiene Regulation7 and GoodManufacturing Practice.
4. Conclusion
The FEEDAP Panel cannot conclude on the safety and the efficacy of the additive FRA® Octazyme C
Dry for weaned piglets and chickens for fattening based on the additional data submitted.
5. Recommendation
The Panel considers that methods allowing for quantification of the recommended enzyme activities
in the feedingstuffs should be developed.
Documentation as provided to EFSA/Chronology
Date Event
30/07/2018 Dossier received by EFSA. FRA® Octazyme C Dry. Submitted by Framelco B.V.
11/10/2018 Reception mandate from the European Commission
24/10/2018 Application validated by EFSA – Start of the scientific assessment
20/12/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientific assessment suspended. Issues: safety for the consumer
28/01/2018 Reception of supplementary information from the applicant - Scientific assessment re-started
16/05/2019 Opinion adopted by the FEEDAP Panel. End of the Scientific assessment
6 FAD-2018-0052/Supplementary information February 2018/Annexes 2.a to 5.b.
7 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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Appendix A – Enzyme activity in the feeds used in the tolerance and efficacy trials in target species
Table A.1: Mean analysed enzyme activity previously reported (previous) or newly submitted (new) for the diets used in the efficacy trials in chickens for
fattening and piglets
Xylanase Mannanase Amylase Glucanase Protease Cellulase Pectinase GalactosidaseTrial Species Diet
BXU/kg UM/kg UA/kg BU/kg UPR/kg UG/kg UP/kg GALU/kg
Expected at
50 mg/kg
8,000 50 500 1,000 75 160 105 4
Tolerance Chickens Control – previous 5,877 110 11,027 470 < 10 < 10 61 70
Control – new 5,724 77 514 39 0 0 0 0
50 mg/kg – previous 10,830 139 9,603 2,640 151 < 10 133 64
50 mg/kg – new 10,567 164 1,779 1,388 72 170 119 7
5,000 mg/kg – previous 359,600 279 21,367 42,200 103 1,048 2,983 113
5,000 mg/kg – new 575,098 2,333 29,274 109,323 4,857 8,826 6,930 296
Tolerance Weaned
piglets(1)
Control – previous 122,000 < 10 104,000 64,100 336 1,680 65,700 726
Control – new 3,343 49 511 3,840 0 0 64 3
50 mg/kg – previous 20,464 444 36,300 3,550 171 < 10 925 268
50 mg/kg – new 9,597 226 2,591 8,050 118 287 226 49
5,000 mg/kg – previous 759,000 638 85,650 67,950 400 1670 51,400 682
5,000 mg/kg – new 699,207 4,702 52,784 57,488 5,987 8,752 17,900 302
(1): Two basal diets, pre-starter and starter, were used in the study. For the control diet the enzyme activities provided for the starter diet were not considered since it was indicated that they
belonged to the starter diet containing 5,000 mg additive/kg feed.
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Table A.2: Mean analysed enzyme activities previously reported (previous) and newly submitted (new) in the diets used in the efficacy trials in chickens
for fattening
Xylanase Mannanase Amylase Glucanase Protease Cellulase Pectinase Galactosidase
Trial
Basal
diet
Diet
BXU/kg UM/kg UA/kg BU/kg UPR/kg UG/kg UP/kg GALU/kg
Expected at
50 mg/kg
8,000 50 500 1,000 75 160 105 4
Efficacy 1 Wheat Control – previous 7,166 < 200 15,666 < 4,000 < 1,500 320 49 264
Control – new 3,391 0 898 1,213 41 0 4 12
50 mg/kg – previous 7,976 < 200 52,033 6,066 < 1,500 365 118 264
50 mg/kg – new 7,674 96 18,740 2,514 89 183 78 34
Maize Control – previous 4,433 < 200 2,317 < 4,000 < 1,500 < 300 22 65
Control – new 1,608 0 709 585 7 42 3 12
50 mg/kg – previous 6,223 < 200 7,640 6,500 < 1,500 < 300 66 67
50 mg/kg – new 6,591 157 2,849 2,668 291 200 79 49
Efficacy 2 Wheat Control – previous 7,267 < 200 26,333 7,000 3,000 340 37 180
Control – new 1,983 0 690 529 30 36 0 16
50 mg/kg – previous 6,677 < 200 24,067 7,050 < 1,500 310 92 122
50 mg/kg – new 8,225 184 6,752 916 135 294 80 42
Maize Control – previous 6,600 < 200 8,333 < 4,000 < 1,500 < 300 19 60
Control – new 1,835 33 1,748 332 0 0 0 11
50 mg/kg – previous 22,213 < 200 311,077 58,500 < 1,500 154,000 152 39
50 mg/kg – new 12,102 141 4,214 7,701 125 368 116 24
Efficacy 3 Wheat Control – previous 7,900 < 200 21,000 4,233 5,167 383 70 404
Control – new 1,197 0 585 284 62 0 6 10
50 mg/kg – previous 5,443 < 200 23,533 6,733 < 1,500 330 75 159
50 mg/kg – new 7,141 144 4,942 1,694 209 310 92 22
Maize Control – previous 9,500 < 200 10,067 7,867 < 1,500 320 53 178
Control – new 1,765 30 557 452 0 0 0 2
50 mg/kg – previous 7,560 < 200 7,073 5,033 1,500 < 300 84 68
50 mg/kg – new 10,209 140 2,587 1,490 91 185 101 15
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Table A.3: Mean analysed enzyme activities previously reported (previous) or newly submitted (new) in the diets used in the efficacy trials in weaned
piglets
Xylanase Mannanase Amylase Glucanase Protease Cellulase Pectinase Galactosidase
Trial Diet
BXU/kg UM/kg UA/kg BU/kg UPR/kg UG/kg UP/kg GALU/kg
Expected at 50 mg/kg 8,000 50 500 1,000 75 160 105 4
Efficacy 1 Control – previous 5,550 < 200 2,150 < 4,000 < 1,500 < 300 34 31
Control – new 628.5 0 535.5 193.5 6 56 3.5 0
50 mg/kg – previous 4,705 < 200 6,090 5,250 < 1,500 < 300 129 58
50 mg/kg – new 7,565 178 4,352 2,329 72 293 91 25
Efficacy 2(1) Control – previous 122,000 < 10 104,000 64,100 336 1,680 65,700 726
Control – new 3,343 49 511 3,840 0 0 64 3
50 mg/kg – previous 20,464 444 36,300 3,550 171 < 10 925 268
50 mg/kg – new 9,597 226 2,591 8,050 118 287 226 49
Efficacy 3 Control – previous 12,550 < 200 9,735 5,840 < 150 232 135 61
Control – new 2,543 0 583 621 11 69 14 2
50 mg/kg – previous 12,700 < 200 2,135 5,840 < 200 215 523 31
50 mg/kg – new 11,813 114 4,111 2,456 119 342 152 10
(1): Two basal diets, pre-starter and starter, were used in the study. For the control diet, the enzyme activities provided for the starter diet were not considered since it was indicated that they
belonged to the starter diet containing 5,000 mg additive/kg feed (see tolerance trial).
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